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Abstract 
The sequence and genomic organization of the CACNA1A gene that encodes the Cav2.1 subunit 
of both P and Q type Ca2+ channels are well conserved in mammals. In human, rat and mouse 
CACNA1A, the use of an alternative acceptor site at the exon 46-47 boundary results in the 
expression of a long Cav2.1 splice variant. In transfected cells, the long isoform of human 
Cav2.1 produces a C-terminal fragment, but it is not known whether this fragment affects 
Cav2.1 expression or functional properties. Here, we cloned the long isoform of rat Cav2.1 
(Cav2.1(e47)) and identified a novel variant with a shorter C-terminus (Cav2.1(e47s)) that 
differs from those previously described in the rat and mouse. When expressed in Xenopus laevis 
oocytes, Cav2.1(e47) and Cav2.1(e47s) displayed similar functional properties as the short 
isoform (Cav2.1). We show that Cav2.1 isoforms produced short (CT1) and long (CT1(e47)) 
C-terminal fragments that interacted in vivo with the auxiliary Cav4a subunit. Overexpression 
of the C-terminal fragments did not affect Cav2.1 expression and functional properties. 
Furthermore, the functional properties of a Cav2.1 mutant without the C-terminal Cav4 
binding domain (Cav2.1CT2) were similar to those of Cav2.1, and were not influenced by the 
co-expression of the missing fragments (CT2 or CT2(e47)). Our results exclude a functional 
role of the C-terminal fragments in Cav2.1 biophysical properties in an expression system 
widely used to study this channel. 
 
  
1 INTRODUCTION 
Voltage gated Ca2+ channels are heteromultimeric assemblies of the pore-forming Cav1 
subunit and of the auxiliary subunits Cav and Cav2. The human genome contains ten genes 
encoding Cav1 subunits (Cav1.1 to 1.4, Cav2.1 to 2.3 and Cav3.1 to 3.3), four genes encoding 
Cav subunits (Cav1-4), and four genes encoding Cav2 subunits (Cav21-4). The 
interactions between Cav1 and its auxiliary subunits determine the channel expression level 
and functional properties (Buraei & Yang, 2010). The Cav2.1 subunit is the pore-forming 
subunit of the P- and Q-type Ca2+ channels (Pinto et al., 1998; Jun et al., 1999) that are widely 
expressed in the central nervous system, particularly in the cerebellum where they were first 
described (Mintz et al., 1992; McDonough et al., 1996). The pharmacological and functional 
properties that differentiate P- from Q-type channels result from alternative splicing of the 
Cav2.1 subunit and specific co-expression of one auxiliary Cav subunit (Hans et al., 1999; 
Kanumilli et al., 2006). C-terminal Cav2.1 variants are created by insertion/omission of the 
GGCAG sequence at the beginning of exon 47 (Fig. 1). However, this insertion is not the only 
event that diversifies the C-terminal extremity of Cav2.1. Specifically, the rabbit BI-1 variant 
lacks the GGCAG insertion, but harbors a sequence closely related to that found in human exon 
47 (Andrés-Mateos et al., 2006). Conversely, the rabbit BI-2 variant results from the removal 
of the exon 46 end and the first third of exon 47 (Mori et al., 1991). Similar recombination 
events have also been described in the human CACNA1A gene, although they lead to isoforms 
that are completely different from BI-2 (Zhuchenko et al., 1997; Veneziano et al., 2009). A 
mouse isoform with a fully translated exon 47, similar to the human sequence, has been 
described (Richards et al., 2007), but other isoforms also exist. For instance, MPII (BAB85612) 
results from the use of an alternative acceptor site at the beginning of exon 47 (Fig. 1) that leads 
to the expression of a unique sequence up to the deletion of a single base allowing the recovery 
of the original reading frame of the fully translated exon 47. Therefore, MPII C-terminus is 
close to that of the human subunit (Tsunemi et al., 2002). In the MPI isoform (BAB85611), 
deletion of 150 nucleotides in exon 47 produces a translational frameshift, leading to a specific 
C-terminal sequence (Tsunemi et al., 2002). Given the high degree of sequence conservation in 
Cav2.1 and the similarities in the CACNA1 gene organization in different species (Soong et al., 
2002; Kanumilli et al., 2006), such variability in the Cav2.1 C-terminus is quite intriguing. 
Moreover, it is not clear whether and how these specific sequences affect the functional 
properties of Cav2.1 channels. 
Interestingly, when the human Cav2.1 subunit is expressed in HEK cells, a 60-75kDa fragment 
(1ACT) that contains a tract of glutamine residues (polyQ) can be detected in cell nuclei with 
antibodies against the Cav1 C-terminus (Kubodera et al., 2003; Kordasiewicz et al., 2006). 
The 1ACT protein is translated through an internal ribosome entry site (IRES) located within 
the mature mRNA encoding the Cav2.1 subunit (Du et al., 2013), and may act as a transcription 
factor that modulates the expression of genes involved in neural development (Du et al., 2013). 
Importantly, 1ACT harboring a pathologic polyQ expansion, as observed in spinocerebellar 
ataxia type 6 (SCA6), cannot upregulate these genes (Du et al., 2013; Ishida et al., 2016; 
Bavassano et al., 2017). SCA6 is an autosomal dominant cerebellar ataxia caused by expansion 
of this polyQ tract and characterized by the formation of insoluble aggregates in cerebellar 
Purkinje cells. Due to alternative splicing, the polyQ expansion is present in the Cav2.1 subunit 
with an extended C-terminus, but not in the short isoforms (Zhuchenko et al., 1997). Studies 
on the functional impact of the pathological polyQ expansion in Cav2.1 gave rise to 
discrepancies, probably due to differences in the used Cav2.1 isoforms and/or cell lines 
(Matsuyama et al., 1999; Restituito et al., 2000; Toru et al., 2000; Piedras-Renteria et al., 2001). 
However, the functional properties of human Cav2.1 harboring a pathological polyQ expansion 
are not affected in Purkinje cells isolated from a knock-in mouse model of SCA6 (Saegusa et 
al., 2007).  
Unlike many other species, the rat and mouse Cacna1a genes are devoid of CAG repeats 
(Andrés-Mateos et al., 2006), thus precluding the additional level of complexity of 1ACT 
functions brought by the polyQ expansion. Rat Cav2.1 with an extended C-terminus encoded 
by exon 47 (called herein Cav2.1(e47)) (Fig. 1) has not been functionally characterized yet and 
only the short variant Cav2.1 (called herein Cav2.1) is currently available for functional studies. 
Therefore, here we used Xenopus laevis oocytes, a heterologous expression system that has 
been used to study Cav2.1 calcium channels for nearly three decades, to determine whether a 
similar C-terminal fragment is produced also in oocytes that express rat Cav2.1, and whether 
co-expression of this fragment and Cav2.1 affects the channel properties. Indeed, Cav1 C-
terminus interacts with the Cav4 subunits or other regions of the Cav subunit (Sandoz et al., 
2001; Geib et al., 2002). To this aim, we cloned a novel variant of the extended rat Cav2.1 C-
terminus (Cav2.1(e47s)), in addition to Cav2.1(e47). We found that the electrophysiological 
properties of Cav2.1(e47) and Cav2.1(e47s) do not differ from those of Cav2.1, when expressed 
in X. laevis oocytes with Cav4a, 1b or 2a. Moreover, Cav2.1, Cav2.1(e47) and Cav2.1(e47s) 
produced C-terminal fragments equivalent to those produced by the human gene. These short 
and long C-terminal fragments (CT1 and CT1(e47), respectively) interacted with Cav4a in co-
immunoprecipitation assays. Co-expression of C-terminal fragments with Cav2.1 or with a 
truncated Cav2.1 that lacks most of the C-terminus did not affect the channel expression or 
functional properties. Our study brings new important findings on rat Cav2.1 isoforms and 
clarifies the role of the C-terminal fragments expressed with the full-length channel in X. laevis 
oocytes. 
 
  
2 MATERIAL AND METHODS 
2.1 Molecular biology 
The rat brain Cav2.1 (Genbank accession number AAA40806), Cav1b (CAA43665), Cav2a 
(AAK14821), Cav4a (A45982), and Cav21 (AAG28164) cDNAs were cloned in the pMT2 
and pcDNA3.1(+) (for Cav21) expression vectors. The fragment encoding Cav2.1 exon 47 
was obtained by RT-PCR using specific oligonucleotides and rat cerebellum total RNA (Agilent 
Technologies). Sequencing of several clones after cloning in the pBS-SK vector (Agilent 
technologies) revealed the existence of two fragments: TCA50 (full length exon 47) and TCA56 
(with a 213nt deletion). They were cloned in frame with rat Cav2.1 in pMT2 using conventional 
molecular biology techniques to obtain Cav2.1(e47) and Cav2.1(e47s), respectively. Cav2.1, 
Cav2.1(e47) and Cav2.1(e47s) were also cloned in the pEGFP-N1 expression vector (Clontech) 
in frame with GFP to obtain Cav2.1-GFP, Cav2.1(e47)-GFP and Cav2.1(e47s)-GFP. The C-
terminal fragments CT1, CT1(e47), CT2, and CT2(e47) were PCR amplified, cloned in frame 
with the RGS-6His tag in a modified pEGFP-N1 vector in which the GFP-encoding sequence 
was exchanged with the sequence encoding the RGS-6His tag to obtain CT1-6His, CT1(e47)-
6His, CT2-6His, and CT2(e47)-6His. CT1 and CT1(e47) were also cloned in pEGFP-N1 in 
frame with GFP to generate CT1-GFP and CT1(e47)-GFP. For the production of Cav2.1CT1 
and Cav2.1CT2, a stop codon was introduced by PCR after residue K1906 (numbered 
according to the AAA40806 sequence) or A2043, respectively. The amplified C-terminal 
fragments were cloned in pBS-SK, fully sequenced, and then, conventional molecular biology 
techniques were used to put them at the place of the full length Cav2.1 C terminus. For X. laevis 
oocyte injections, a cDNA mixture at a molar ratio of 1:1:1 (Cav:Cav:Cav2) was prepared 
with the addition of water or the cDNA encoding one of the C-terminal fragments tagged with 
RGS-6His at a molar ratio of 1:1:1:1, unless otherwise indicated. 
2.2 Ethical statement 
This study was carried out in strict accordance with the recommendations and relevant 
guidelines of our institution. Surgery was performed under anesthesia, and efforts were made 
to minimize suffering. The care and use of Xenopus conformed to institutional policies and 
guidelines. The experimental protocols were approved by the "Direction Départementale des 
Services Vétérinaires" (authorization N° C34.16). 
2.3 X. laevis oocyte preparation and injection 
Preparation and injection of X. laevis oocytes were done as previously described (Cens et al., 
1996). After injection of about 15 ng of cDNA, oocytes were maintained at 19°C in NDS buffer 
(96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM Hepes, 2.5 mM Na-Pyruvate, 
0.05 mM gentamycin, pH 7.2 with NaOH) renewed daily. 
2.4 Electrophysiology 
Expressed currents were recorded at room temperature using the two-electrode voltage clamp 
method at day 1-3 after injection, as previously described (Cens et al., 2008). Electrodes were 
pulled from borosilicate glass and filled with 3M KCl. Currents were recorded with a 
Geneclamp 500 amplifier (Molecular Devices), and digitized with a Digidata 1200 converter 
(Molecular Devices) using the Clampex software (Molecular Devices). The external solution 
(10mM BaOH, 20mM TEAOH, 2mM CsOH, 50mM N-methyl-D-glucamine, 10mM HEPES, 
pH 7.2 with methane sulfonic acid) was continuously perfused in the recording chamber at the 
rate of 1 mL/min. 
Currents were elicited by a two-pulse protocol from a holding potential of -100 mV. The first 
pulse lasted for 2.5 s and varied from -80 to +50 mV in 10 mV increments. The second pulse, 
separated from the first pulse by a 10 ms interval at -100 mV, lasted for 400 ms and was set at 
+10 mV. The isochronal inactivation curves were obtained by measuring the peak amplitude of 
the current evoked by the second pulse and by plotting the normalized current values (I/Imax) 
as a function of the voltage reached during the first pulse. They were fitted using the following 
equation: 
I/Imax = Rin + (1-Rin)/(1+exp((V-Vi)/k)) 
where I is the current amplitude measured during the second pulse following a first 
depolarization to V, Imax is the current amplitude measured during the second pulse following 
a first pulse at -80 mV, Vi is the half inactivation potential, k is a slope factor and Rin is the 
portion of non-inactivating current. 
Currents were also elicited by single 400 ms-long depolarizations varying from -60 mV to +40 
mV, from a holding potential of -100 mV. Current-voltage curves were obtained by measuring 
the peak amplitude and by plotting the normalized current values (I/Imax) as a function of the 
voltage. They were fitted using the following equation: 
I/Imax = G (V-Erev)/(1+exp((V-Va)/k)) 
where I is the current amplitude measured during the depolarization to V, Imax is the peak 
current amplitude measured at the maximum of the current-voltage curve, G is the normalized 
macroscopic conductance, Erev is the apparent reversal potential, Va is the potential for half 
activation, and k is a slope factor. The inactivation velocity (R400) was estimated as the 
percentage of the peak current that disappeared after 400ms-long depolarizations to +10 mV. 
Recovery from inactivation was determined using a protocol with two pulses at +10 mV for 5 
s or 100 ms, respectively, from a holding potential of -100 mV, separated by an interval of time 
between 100 ms and 8 s. Traces were normalized to the maximum current measured during the 
first pulse. The percentage of current recovered during the second pulse was plotted as a 
function of the inter-pulse interval. Traces were fit with a double exponential equation. 
2.5 Western blotting and immunoprecipitation assays 
Oocytes that expressed Cav1-GFP alone or with 6His-tagged C-terminal fragments were 
harvested in 10 mM Tris HCl pH 7.5, 1 mM PMSF, 1 mM EDTA pH 8, and Complete Protease 
Inhibitor (Roche). Lysates were homogenized with one volume of 2% Triton X100, 20 mM 
Tris pH 7.5, 300 mM NaCl, 1 mM EDTA, and incubated on ice for 1 hour. A volume of lysate 
corresponding to ~2 oocytes (i.e., an amount sufficient to generate ~4A total current amplitude 
measured at +10 mV) was separated on Mini-PROTEAN® TGXTM Pre-Cast Gels (BioRad). 
Immunoblotting was performed with rabbit anti-GFP (1:5000, Sigma-Aldrich 
Cat#SAB4301138, RRID: AB_2750576), and mouse anti-RGS6His (1:1000, QIAGEN 
Cat#3460, RRID: AB_2687898), and horseradish peroxidase-conjugated goat anti-rabbit 
(1:5000, Sigma-Aldrich Cat#A0545, RRID: AB_257896) antibodies or horseradish peroxidase-
conjugated goat anti-mouse (1:5000, Sigma-Aldrich Cat#A9917, RRID: AB_258476). 
HEK293 cells (RRID: CVCL_0045) were transfected with CT1-GFP or CT1(e47)-GFP alone, 
or together with Cav4 using Lipofectamine (ThermoFisher). At 24h post-transfection, cells 
were harvested in RIPA Lysis Buffer (Boster) with 1 mM PMSF, 1 mM EDTA pH 8, and 
Complete Protease Inhibitor. Cell lysates were incubated with a prewashed slurry of 20 l anti-
GFP-Trap® A beads (Chromotek) at 4°C for 2h. Immunoprecipitates were recovered in 0.2 M 
glycine pH 2.5. Cells lysates and immunoprecipitates were analyzed separately using rabbit 
anti-GFP (1:5000), mouse anti-Cav4 (1:1000, abcam Cat#85788, RRID: AB_1860050), rabbit 
anti-GAPDH (1:5000, Sigma-Aldrich Cat#G9545, RRID: AB_796208), and horseradish 
peroxidase-conjugated goat anti-rabbit (1:5000) or goat anti-mouse (1:5000) antibodies. 
Detection was performed with the Western Lightning Plus (Perkin Elmer) reagents. 
2.6 Data analysis 
Results were expressed as the mean ± SEM. The statistical significance of differences between 
two groups was determined using the non-paired Student’s t test. 
  
3 RESULTS 
3.1 Cloning and functional expression of two long variants of the rat Cav2.1 subunit 
A cDNA fragment (AAC24516) encoding the entire exon 47 of the rat Cav2.1 calcium channel 
was previously isolated from pancreas (Ligon et al., 1998), and a partial clone that lacks 123 
nucleotides in exon 47 sequence (CAJ09863) was obtained from rat Purkinje neurons 
(Kanumilli et al., 2006)(Fig. 1). However, to our knowledge, no cDNA encoding the rat Cav2.1 
with the long C-terminus is available for functional studies. Therefore, we designed 
oligonucleotides to amplify rat exon 47 from cerebellum RNA and obtained two different 
variants. The first one (TCA50, Fig. 1) encoded the entire exon 47 and was identical to the 
AAC24516 sequence and similar to a clone (AAW56205) isolated from mouse brain (Richards 
et al., 2007). The second variant (TCA56, Fig. 1) lacked 213 nucleotides compared with 
TCA50. The deletion in TCA56 was different from the one found in CAJ09863 (Fig. 1) and 
produced a novel rat Cav2.1 variant. Both deletions were similar to those found in mouse 
Purkinje neurons (Tsunemi et al., 2002), but due to frameshifts of the open reading frame, the 
amino acid sequences of the mouse variants differ substantially at the N- (BAB85612) or the 
C-terminus (BAB85611) of exon 47 (Fig. 1b). We constructed two cDNAs [Cav2.1(e47) and 
Cav2.1(e47s)] that encode the rat Cav2.1 subunit with full length exon 47 (i.e., TCA50) and the 
shorter variant (i.e., TCA56), respectively (Fig. 2a). When co-expressed with the Cav4a and 
Cav21 subunits in X. laevis oocytes (Fig. 2b), Cav2.1, Cav2.1(e47) and Cav2.1(e47s) 
displayed globally similar electrophysiological properties (Fig. 2c and Table 1). The 
inactivation kinetics, estimated using the mean R400 values, were also comparable (Fig. 2c and 
Table 1). We obtained similar results when the three Cav2.1 variants were co-expressed with 
Cav1b or Cav2a that accelerates or decelerates inactivation, respectively, instead of Cav4a 
(Table 1). We next investigated the recovery from inactivation that is slower for the human long 
Cav2.1 isoform compared with the short isoform (Adams et al., 2009), but we did not observe 
this difference when using rat Cav2.1 and Cav2.1(e47) or Cav2.1(e47s) (Fig. 3). 
3.2 The rat Cav2.1 transcripts produce C-terminal fragments in X. laevis oocytes 
Human long Cav2.1 produces a C-terminal fragment (1ACT) when expressed in HEK or 
PC12 cells (Kubodera et al., 2003; Kordasiewicz et al., 2006; Ishiguro et al., 2010). However, 
little is known about the Cav2.1 isoform with the shorter C-terminus and whether C-terminal 
fragments are produced when the channel is expressed in X. laevis oocytes. Therefore, we co-
injected the Cav4 and Cav21 subunits with rat Cav2.1-GFP, Cav2.1(e47)-GFP, or 
Cav2.1(e47s)-GFP in X. laevis oocytes and selected expressing oocytes. Western blot analysis 
with an anti-GFP antibody (Fig. 4a) showed the presence of full-length Cav1 (band above 
250kDa) and of additional bands between 60-90kDa. This demonstrated that rat Cav2.1 
produces C-terminal fragments, like human Cav2.1, independently of the presence of exon 47. 
These C-terminal fragments might influence the expression and electrophysiological properties 
of Cav2.1 channels. Indeed, it was previously shown that Cav4 interacts specifically with a C-
terminus binding domain (SS2) in the rabbit Cav2.1 isoforms BI-1 and BI-2 (Walker et al., 
1999; Sandoz et al., 2001). Therefore, we generated two Cav2.1 C-terminal fragments that start 
at residue I1907 (according to the AAA40806 sequence) and encompass the full-length exon 
47 (CT1(e47)) or the C-terminal sequence of the Cav2.1 isoform without exon 47 (CT1) (Fig. 
5a). We then expressed C-terminally GFP-tagged CT1 and CT1(e47) together with Cav4 in 
HEK293 cells. Co-immunoprecipitation assays of protein lysates showed that both CT1 and 
CT1(e47) interacted with Cav4 (Fig. 4b). These findings indicate that in X. laevis oocytes 
functional Cav2.1 channels coexist with C-terminal fragments, and that these fragments can 
interact with channel partners, such as Cav4a. 
3.3 Over-expression of C-terminal fragments do not affect Cav2.1 expression and functional 
properties in X. laevis oocytes 
To evaluate the functional role of the Cav2.1 C-terminus and the potential influence of the 
different C-terminal fragments, we also generated a rat Cav2.1 subunit that lacks the CT1 
fragment (Cav2.1CT1, Fig. 5a). When co-expressed with Cav4 and Cav21 in X. laevis 
oocytes, Cav2.1CT1 did not produce functional channels (Fig. 5b) even after co-expression 
of CT1 (not shown). Moreover, co-injection of Cav4 and Cav21 with Cav2.1 and CT1 or 
CT1(e47) (1:1:1:1 molar ratio) did not, or marginally, affect the parameters of the current-
voltage curves, of the inactivation curves, and the R400 values (Fig. 5c and Table 1). We 
confirmed the expression of the His-tagged C-terminal fragments in X. laevis oocytes by 
Western blot analysis after the recordings (Fig. 5d). As these fragments interact with the Cav4 
subunit (see Fig. 4b), we tested whether they could inhibit Cav2.1 expression when injected in 
excess relative to the cDNA encoding Cav2.1, Cav4 and Cav21 (molar ratio 1:1:1:5). 
However, the percentage of expressing oocytes was similar when Cav2.1 was expressed alone 
or with CT1 or CT1(e47) (44%, 43%, and 36%, respectively, four independent experiments) 
(Fig. 5e (left panel)), suggesting that the C-terminal fragments did not inhibit Cav2.1 expression 
by titrating the Cav4 subunit. We confirmed this lack of effect by systematically measuring 
the current amplitude in all the expressing oocytes in a single experiment. Indeed, we found 
similar mean current amplitude values for Cav2.1 expressed alone or with CT1 or CT1(e47) 
(Fig. 5e (right panel)). Cav2.1 voltage-dependent properties and inactivation kinetics also were 
not affected after injection in excess of C-terminal fragments (Table 1). 
The effect of the co-expressed C-terminal fragments could have been hindered by the presence 
of the C-terminus in the Cav2.1 subunit. As CT1 deletion (Cav2.1CT1) affects functional 
expression, we introduced a stop codon after residue A2043 (according to the AAA40806 
sequence) just before the SS2 binding domain (Cav2.1CT2, Fig. 6a). When co-expressed with 
Cav4a and Cav21 in X. laevis oocytes, Cav2.1CT2 gave rise to functional channels (Fig. 
6c). Moreover, Cav2.1CT2 electrophysiological properties were undistinguishable from those 
of Cav2.1 (Fig. 6d and Table 1). Co-expression with CT2 or CT2(e47) (Fig. 6a) did not modify 
Cav2.1CT2 properties (Fig. 6d and Table 1). We confirmed CT2 and CT2(e47) expression in 
the recorded oocytes by Western blotting (Fig. 6b). These results suggest that the lack of effects 
of the C-terminal fragments observed with full-length Cav2.1 was not due to the presence of 
the C-terminus in Cav2.1.  
  
4 DISCUSSION 
In this study, we cloned Cav2.1(e47) and Cav2.1(e47s), two C-terminal variants of the rat 
Cav2.1 subunit that harbor the full length (TCA50) or a shorter variant (TCA56) of exon 47 
(Fig. 1) respectively, and analyzed their functional properties after expression in X. laevis 
oocytes. Whatever the co-expressed Cav subunit (Cav1b, Cav2a or Cav4a), the 
electrophysiological properties of Cav2.1(e47) and Cav2.1(e47s) were comparable to those of 
the short Cav2.1 isoform. Moreover, these three Cav2.1 isoforms produced C-terminal 
fragments, like the human CACNA1A gene. These fragments interacted with the Cav4a subunit 
in co-immunoprecipitation assays. However, overexpression of these C-terminal fragments 
with full length Cav2.1 did not modify the expression or the functional properties of the 
channel. 
Exon 47 is present only in some Cav2.1 isoforms because the retention of the GGCAG sequence 
produces a frameshift of the reading frame (see Fig. 1). Based on our results, we can expect that 
exon 47 might be expressed in some isoforms of 1ACT. Comparison of the different C-
terminus variants among species highlights differences in the events leading to their production 
and also in their sequences. On the other hand, when expressed in HEK293 cells, the three 
mouse Cav2.1 variants (the short MPc, and the two MPI and MPII variants) show similar 
electrophysiological properties (Tsunemi et al., 2002). Although the C-terminal sequences of 
the mouse and rat variants are different, these results are consistent with our observations in X. 
laevis oocytes. The channel activation and inactivation processes are not affected by Cav2.1 
variants with different C-terminal sequence (mouse MPI and MPII, and rat Cav2.1(e47) and 
Cav2.1(e47s)). Similar results were obtained in a study that compared the properties of human 
Cav2.1 with or without extended C-terminus (fully translated exon 47 with 11 Q residues in the 
polyQ expansion) co-expressed in HEK293 cells with Cav4 (Adams et al., 2009) or in another 
study that used human/mouse chimeric Cav2.1 channels also expressed in HEK293 cells 
(human Cav2.1 sequence with murine exon 47) (Heck et al., 2019). However, the recovery 
from inactivation was slower and inactivation accumulation was greater for the long than for 
the short Cav2.1 variant (Adams et al., 2009). Although the rabbit BI-1 and BI-2 variants are 
quite different (the C terminus of the long isoform BI-2 harbors an additional Cav binding site 
besides SS2) (Sandoz et al., 2001), the functional properties of both subunits are very similar 
when expressed with Cav3 or Cav4. Indeed, the additional Cav binding domain in BI-2 
seems to affect only the current density (Sandoz et al., 2001). The sequence of the Cav4 SS2 
binding domain is well conserved among species, and our results show that rat Cav2.1 C-
terminus binds to Cav4, as previously reported for the rabbit Cav2.1 subunit (Walker et al., 
1998; Sandoz et al., 2001). However, the results obtained with Cav2.1CT2 (without the SS2 
binding domain) seem to exclude a functional role for this interaction site when the channel is 
expressed at the plasma membrane. A similar deletion in a mouse Cav2.1 variant did not affect 
expression or functional properties when expressed at the calyx of Held in a knock-in mouse 
model (Lübbert et al., 2017). 
In the majority of the central nervous system synapses, P/Q-type calcium channels are the 
principal Ca2+ channels that trigger the neurotransmitter release. This results from specific 
interactions between the Cav2.1 subunit and several scaffold proteins that mediate the link 
between Ca2+ channels, synaptic vesicles, and the exocytosis machinery. Indeed, in Cav2.1, the 
cytoplasmic loop that links domains II and III contains a synprint interaction domain for the 
interaction with synaptic proteins, such as syntaxin-1 and synaptotagmin (Rettig et al., 1996; 
Charvin et al., 1997). This domain is also found in the Cav2.2 subunit that encodes the N-type 
Ca2+ channel, involved in neurotransmission. Interestingly, a Cav2.2 variant in which the 
synprint domain is missing has been identified in the human brain (Kaneko et al., 2002). Other 
sites for the interactions with RIM, MINT1, Rim Binding Proteins and CASK, important for 
the synaptic localization of the Cav2.1 subunit, are localized in Cav C-terminus (Maximov et 
al., 1999; Hibino et al., 2002; Kaeser et al., 2011). The relative importance of each of these 
interactions for Cav2.1 targeting to the presynaptic active zone is a matter of debate (Lübbert 
et al., 2017), but it is interesting that some of these binding sites are encoded by exon 47, and 
are therefore not found in all Cav2.1 variants (Hirano et al., 2017). In a recent study, Heck and 
colleagues found that the different release probability and short-term plasticity of hippocampal 
synapses that express Cav2.1 with or without exon 47 are due to a difference in surface mobility 
between these channels (Heck et al., 2019). It is tempting to speculate that Cav2.1 isoforms 
with different exon 47 variants might specifically modulate these properties. 
In conclusion, our results exclude a functional role of the C-terminal fragments on Cav2.1 
expression level and electrophysiological properties when expressed in X. laevis oocytes. 
Therefore, we could hypothesize that Cav2.1 C-terminus is mainly involved in Cav2.1 
trafficking to specific cellular compartments. Moreover, we found that the C-terminal 
fragments produced by the Cav2.1 transcripts may contain different splice variants, especially 
in exon 47 sequence. These fragments, produced thanks to the presence of an IRES, regulate 
the expression of specific genes (Du et al., 2013). Interestingly, the pathological pQ expansion 
found in patients with SCA6 abolishes the transcriptional activity of 1ACT. Thus, the 
transcriptional roles of the C-terminal fragments in mouse, rat and rabbit Cav2.1, or of human 
Cav2.1 without pQ expansion but with a specific C-terminal sequence need to be investigated. 
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IRES – internal ribosome entry site 
SCA6 – spinocerebellar ataxia type 6 
X. laevis – Xenopus laevis 
REFERENCES 
Adams, P.J., Garcia, E., David, L.S., Mulatz, K.J., Spacey, S.D., & Snutch, T.P. (2009) 
Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of 
familial hemiplegic migraine mutations: implications for calcium channelopathies. 
Channels, 3, 110–121. 
Andrés-Mateos, E., Cruces, J., Renart, J., Solís-Garrido, L.M., Serantes, R., de Lucas-Cerrillo, 
A.M., & Montiel, C. (2006) Bovine CACNA1A gene and comparative analysis of the 
CAG repeats associated to human spinocerebellar ataxia type-6. Gene, 380, 54–61. 
Bavassano, C., Eigentler, A., Stanika, R., Obermair, G.J., Boesch, S., Dechant, G., & Nat, R. 
(2017) Bicistronic CACNA1A Gene Expression in Neurons Derived from 
Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells. Stem Cells Dev., 
26, 1612–1625. 
Buraei, Z. & Yang, J. (2010) The ß subunit of voltage-gated Ca2+ channels. Physiol. Rev., 90, 
1461–1506. 
Cens, T., Leyris, J.-P., & Charnet, P. (2008) Introduction into Ca(v)2.1 of the homologous 
mutation of Ca(v)1.2 causing the Timothy syndrome questions the role of V421 in the 
phenotypic definition of P-type Ca(2+) channel. Pflugers Arch., 457, 417–430. 
Cens, T., Mangoni, M.E., Nargeot, J., & Charnet, P. (1996) Modulation of the α1A Ca2+ 
channel by β subunits at physiological Ca2+ concentration. FEBS Lett., 391, 232–237. 
Charvin, N., Lévêque, C., Walker, D., Berton, F., Raymond, C., Kataoka, M., Shoji-Kasai, Y., 
Takahashi, M., De Waard, M., & Seagar, M.J. (1997) Direct interaction of the calcium 
sensor protein synaptotagmin I with a cytoplasmic domain of the alpha 1A subunit of the 
P/Q-type calcium channel. EMBO J., 16, 4591–4596. 
Du, X., Wang, J., Zhu, H., Rinaldo, L., Lamar, K.-M., Palmenberg, A.C., Hansel, C., & 
Gomez, C.M. (2013) Second cistron in CACNA1A gene encodes a transcription factor 
mediating cerebellar development and SCA6. Cell, 154, 118–133. 
Geib, S., Sandoz, G., Cornet, V., Mabrouk, K., Fund-Saunier, O., Bichet, D., Villaz, M., 
Hoshi, T., Sabatier, J.-M., & De Waard, M. (2002) The interaction between the I-II loop 
and the III-IV loop of Cav2.1 contributes to voltage-dependent inactivation in a beta -
dependent manner. J. Biol. Chem., 277, 10003–10013. 
Hans, M., Urrutia, A., Deal, C., Brust, P.F., Stauderman, K., Ellis, S.B., Harpold, M.M., 
Johnson, E.C., & Williams, M.E. (1999) Structural elements in domain IV that influence 
biophysical and pharmacological properties of human alpha1A-containing high-voltage-
activated calcium channels. Biophys. J., 76, 1384–1400. 
Heck, J., Parutto, P., Ciuraszkiewicz, A., Bikbaev, A., Freund, R., Mitlöhner, J., Andres-
Alonso, M., Fejtova, A., Holcman, D., & Heine, M. (2019) Transient Confinement of 
CaV2.1 Ca2+-Channel Splice Variants Shapes Synaptic Short-Term Plasticity. Neuron, 
103, 66-79.e12. 
Hibino, H., Pironkova, R., Onwumere, O., Vologodskaia, M., Hudspeth, A.J., & Lesage, F. 
(2002) RIM binding proteins (RBPs) couple Rab3-interacting molecules (RIMs) to 
voltage-gated Ca(2+) channels. Neuron, 34, 411–423. 
Hirano, M., Takada, Y., Wong, C.F., Yamaguchi, K., Kotani, H., Kurokawa, T., Mori, M.X., 
Snutch, T.P., Ronjat, M., De Waard, M., & Mori, Y. (2017) C-terminal splice variants of 
P/Q-type Ca2+ channel CaV2.1 α1 subunits are differentially regulated by Rab3-
interacting molecule proteins. J. Biol. Chem., 292, 9365–9381. 
Ishida, Y., Kawakami, H., Kitajima, H., Nishiyama, A., Sasai, Y., Inoue, H., & Muguruma, K. 
(2016) Vulnerability of Purkinje Cells Generated from Spinocerebellar Ataxia Type 6 
Patient-Derived iPSCs. Cell Rep., 17, 1482–1490. 
Ishiguro, T., Ishikawa, K., Takahashi, M., Obayashi, M., Amino, T., Sato, N., Sakamoto, M., 
Fujigasaki, H., Tsuruta, F., Dolmetsch, R., Arai, T., Sasaki, H., Nagashima, K., Kato, T., 
Yamada, M., Takahashi, H., Hashizume, Y., & Mizusawa, H. (2010) The carboxy-
terminal fragment of alpha(1A) calcium channel preferentially aggregates in the 
cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells. Acta Neuropathol., 119, 
447–464. 
Jun, K., Piedras-Rentería, E.S., Smith, S.M., Wheeler, D.B., Lee, S.B., Lee, T.G., Chin, H., 
Adams, M.E., Scheller, R.H., Tsien, R.W., & Shin, H.S. (1999) Ablation of P/Q-type 
Ca(2+) channel currents, altered synaptic transmission, and progressive ataxia in mice 
lacking the alpha(1A)-subunit. Proc. Natl. Acad. Sci. U. S. A., 96, 15245–15250. 
Kaeser, P.S., Deng, L., Wang, Y., Dulubova, I., Liu, X., Rizo, J., & Südhof, T.C. (2011) RIM 
proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain 
interaction. Cell, 144, 282–295. 
Kaneko, S., Cooper, C.B., Nishioka, N., Yamasaki, H., Suzuki, A., Jarvis, S.E., Akaike, A., 
Satoh, M., & Zamponi, G.W. (2002) Identification and characterization of novel human 
Ca(v)2.2 (alpha 1B) calcium channel variants lacking the synaptic protein interaction 
site. J. Neurosci., 22, 82–92. 
Kanumilli, S., Tringham, E.W., Payne, C.E., Dupere, J.R.B., Venkateswarlu, K., & Usowicz, 
M.M. (2006) Alternative splicing generates a smaller assortment of CaV2.1 transcripts in 
cerebellar Purkinje cells than in the cerebellum. Physiol. Genomics, 24, 86–96. 
Kordasiewicz, H.B., Thompson, R.M., Clark, H.B., & Gomez, C.M. (2006) C-termini of P/Q-
type Ca2+ channel alpha1A subunits translocate to nuclei and promote polyglutamine-
mediated toxicity. Hum. Mol. Genet., 15, 1587–1599. 
Kubodera, T., Yokota, T., Ohwada, K., Ishikawa, K., Miura, H., Matsuoka, T., & Mizusawa, 
H. (2003) Proteolytic cleavage and cellular toxicity of the human alpha1A calcium 
channel in spinocerebellar ataxia type 6. Neurosci. Lett., 341, 74–78. 
Ligon, B., Boyd, A.E., & Dunlap, K. (1998) Class A calcium channel variants in pancreatic 
islets and their role in insulin secretion. J. Biol. Chem., 273, 13905–13911. 
Lübbert, M., Goral, R.O., Satterfield, R., Putzke, T., van den Maagdenberg, A.M., Kamasawa, 
N., & Young, S.M. (2017) A novel region in the CaV2.1 α1 subunit C-terminus regulates 
fast synaptic vesicle fusion and vesicle docking at the mammalian presynaptic active 
zone. Elife, 6, e28412. 
Matsuyama, Z., Wakamori, M., Mori, Y., Kawakami, H., Nakamura, S., & Imoto, K. (1999) 
Direct alteration of the P/Q-type Ca2+ channel property by polyglutamine expansion in 
spinocerebellar ataxia 6. J. Neurosci., 19, RC14. 
Maximov, A., Südhof, T.C., & Bezprozvanny, I. (1999) Association of neuronal calcium 
channels with modular adaptor proteins. J. Biol. Chem., 274, 24453–24456. 
McDonough, S.I., Swartz, K.J., Mintz, I.M., Boland, L.M., & Bean, B.P. (1996) Inhibition of 
calcium channels in rat central and peripheral neurons by omega-conotoxin MVIIC. J. 
Neurosci., 16, 2612–2623. 
Mintz, I.M., Adams, M.E., & Bean, B.P. (1992) P-type calcium channels in rat central and 
peripheral neurons. Neuron, 9, 85–95. 
Mori, Y., Friedrich, T., Kim, M.-S., Mikami, A., Nakai, J., Ruth, P., Bosse, E., Hofmann, F., 
Flockerzi, V., Furuichi, T., Mikoshiba, K., Imoto, K., Tanabe, T., & Numa, S. (1991) 
Primary structure and functional expression from complementary DNA of a brain 
calcium channel. Nature, 350, 398–402. 
Piedras-Renteria, E.S., Watase, K., Harata, N., Zhuchenko, O., Zoghbi, H.Y., Lee, C.C., & 
Tsien, R.W. (2001) Increased expression of alpha 1A Ca2+ channel currents arising from 
expanded trinucleotide repeats in spinocerebellar ataxia type 6. J. Neurosci., 21, 9185–
9193. 
Pinto, A., Gillard, S., Moss, F., Whyte, K., Brust, P., Williams, M., Stauderman, K., Harpold, 
M., Lang, B., Newsom-Davis, J., Bleakman, D., Lodge, D., & Boot, J. (1998) Human 
autoantibodies specific for the  1A calcium channel subunit reduce both P-type and Q-
type calcium currents in cerebellar neurons. Proc. Natl. Acad. Sci., 95, 8328–8333. 
Restituito, S., Thompson, R.M., Eliet, J., Raike, R.S., Riedl, M., Charnet, P., & Gomez, C.M. 
(2000) The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta 
subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes. 
J. Neurosci., 20, 6394–6403. 
Rettig, J., Sheng, Z.H., Kim, D.K., Hodson, C.D., Snutch, T.P., & Catterall, W.A. (1996) 
Isoform-specific interaction of the alpha1A subunits of brain Ca2+ channels with the 
presynaptic proteins syntaxin and SNAP-25. Proc. Natl. Acad. Sci. U. S. A., 93, 7363–
7368. 
Richards, K.S., Swensen, A.M., Lipscombe, D., & Bommert, K. (2007) Novel CaV2.1 clone 
replicates many properties of Purkinje cell CaV2.1 current. Eur. J. Neurosci., 26, 2950–
2961. 
Saegusa, H., Wakamori, M., Matsuda, Y., Wang, J., Mori, Y., Zong, S., & Tanabe, T. (2007) 
Properties of human Cav2.1 channel with a spinocerebellar ataxia type 6 mutation 
expressed in Purkinje cells. Mol. Cell. Neurosci., 34, 261–270. 
Sandoz, G., Bichet, D., Cornet, V., Mori, Y., Felix, R., & De Waard, M. (2001) Distinct 
properties and differential beta subunit regulation of two C-terminal isoforms of the P/Q-
type Ca(2+)-channel alpha(1A) subunit. Eur. J. Neurosci., 14, 987–997. 
Soong, T.W., DeMaria, C.D., Alvania, R.S., Zweifel, L.S., Liang, M.C., Mittman, S., Agnew, 
W.S., & Yue, D.T. (2002) Systematic identification of splice variants in human P/Q-type 
channel alpha1(2.1) subunits: implications for current density and Ca2+-dependent 
inactivation. J. Neurosci., 22, 10142–10152. 
Toru, S., Murakoshi, T., Ishikawa, K., Saegusa, H., Fujigasaki, H., Uchihara, T., Nagayama, 
S., Osanai, M., Mizusawa, H., & Tanabe, T. (2000) Spinocerebellar ataxia type 6 
mutation alters P-type calcium channel function. J. Biol. Chem., 275, 10893–10898. 
Tsunemi, T., Saegusa, H., Ishikawa, K., Nagayama, S., Murakoshi, T., Mizusawa, H., & 
Tanabe, T. (2002) Novel Cav2.1 splice variants isolated from Purkinje cells do not 
generate P-type Ca2+ current. J. Biol. Chem., 277, 7214–7221. 
Veneziano, L., Guida, S., Mantuano, E., Bernard, P., Tarantino, P., Boccone, L., Hisama, 
F.M., Carrera, P., Jodice, C., & Frontali, M. (2009) Newly characterised 5’ and 3’ 
regions of CACNA1A gene harbour mutations associated with Familial Hemiplegic 
Migraine and Episodic Ataxia. J. Neurol. Sci., 276, 31–37. 
Walker, D., Bichet, D., Campbell, K.P., & De Waard, M. (1998) A beta 4 isoform-specific 
interaction site in the carboxyl-terminal region of the voltage-dependent Ca2+ channel 
alpha 1A subunit. J. Biol. Chem., 273, 2361–2367. 
Walker, D., Bichet, D., Geib, S., Mori, E., Cornet, V., Snutch, T.P., Mori, Y., & De Waard, 
M. (1999) A new beta subtype-specific interaction in alpha1A subunit controls P/Q-type 
Ca2+ channel activation. J. Biol. Chem., 274, 12383–12390. 
Zhuchenko, O., Bailey, J., Bonnen, P., Ashizawa, T., Stockton, D.W., Amos, C., Dobyns, 
W.B., Subramony, S.H., Zoghbi, H.Y., & Lee, C.C. (1997) Autosomal dominant 
cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-
voltage-dependent calcium channel. Nat. Genet., 15, 62–69. 
 
 
Table 1: Parameters of the voltage-current curves and of the inactivation curves, and R400 values for all the subunit combinations (Cav21 was 
always present). Data are the mean ± S.E.M. of n oocytes. Statistical significance (p values using Student’s t test) vs Cav2.14, p; vs Cav2.11b, 
*p; vs Cav2.12a, **p; vs Cav2.1C24, ***p, is given for all parameters. 
 Current voltage curves Inactivation curves  
 
Va 
(mV) 
ka 
(mV) 
Erev 
(mV) 
n 
Vi 
(mV) 
ki 
(mV) 
R n R400 n 
Cav2.14 -9.0±1.0 -3.2±0.3 54±1 31 -22.9±0.7 7.1±0.2 0.14±0.01 26 0.43±0.02 33 
Cav2.14CT1 
-8.2±1.2 
p=0.62 
-4.5±0.2 
p=0.0005 
51±1 
p=0.0146 
24
-26.0±0.9 
p=0.0094 
8.0±0.3 
p=0.0402 
0.15±0.02 
p=0.71 
14
0.45±0.03 
p=0.35 
22 
Cav2.14CT1 (1:5) 
-11.9±1.4 
p=0.1056 
-3.2±0.4 
p=0.99 
50±1 
p=0.60 
11
-28.2±0.6 
p=0.0003 
6.7±0.2 
p=0.37 
0.12±0.02 
p=0.62 
7 
0.49±0.04 
p=0.1185 
12 
Cav2.14CT1(e47) 
-8.6±1.3 
p=0.65 
-4.1±0.3 
p=0.0077 
53±1 
p=0.37 
28
-27.4±1.0 
p=0.0003 
8.6±0.3 
p=0.0004 
0.09±0.02 
p=0.0376 
21
0.40±0.03 
p=0.55 
34 
Cav2.14CT1(e47) 
(1:5) 
-12.2±1.9 
p=0.2257 
-3.0±0.4 
p=0.81 
50±1 
p=0.1271 
4 
-25.4±0.4 
p=0.1470 
6.7±0.8 
p=0.57 
0.08±0.01 
p=0.1306 
4 
0.48±0.04 
p=0.34 
4 
Cav2.14CT2 
-6.6±1.3 
p=0.1456 
-4.2±0.4 
p=0.0341 
52±2 
p=0.2552 
24
-23.4±1.0 
p=0.69 
7.3±0.2 
p=0.65 
0.13±0.02 
p=0.65 
18
0.39±0.03 
p=0.42 
24 
Cav2.14CT2(e47) 
-9.2±1.1 
p=0.88 
-3.3±0.4 
p=0.84 
55±1 
p=0.40 
20
-25.7±1.1 
p=0.0258 
8.1±0.3 
p=0.0188 
0.11±0.01 
p=0.1011 
18
0.41±0.03 
p=0.82 
20 
Cav2.1(e47)4 
-6.9±1.0 
p=0.1248 
-3.8±0.2 
p=0.1245 
52±1 
p=0.30 
37
-23.4±1.0 
p=0.72 
8.2±0.2 
p=0.0021 
0.08±0.01 
p=0.0003 
35
0.39±0.03 
p=0.35 
21 
Cav2.1(e47s)4 
-7.1±1.1 
p=0.24 
-4.8±0.3 
p=0.0014 
52±1 
p=0.1641 
13
-19.1±1.5 
p=0.0122 
7.1±0.3 
p=0.95 
0.14±0.02 
p=0.99 
14
0.43±0.03 
p=0.73 
15 
Cav2.11b -8.2±0.7 -3.7±0.2 52±1 9 -29.8±0.7 6.8±0.3 0.09±0.01 9 0.33±0.03 9 
Cav2.1(e47)1b 
-11.2±1.3 
*p=0.0544 
-3.4±0.4 
*p=0.42 
52±1 
*p=0.99 
8 
-32.3±1.5 
*p=0.1547 
7.3±0.2 
*p=0.1709 
0.07±0.01 
*p=0.1130 
9 
0.33±0.01 
*p=0.94 
9 
Cav2.1(e47s)1b 
-11.4±1.8 
*p=0.0894 
-3.2±0.2 
*p=0.1159 
51±1 
*p=0.2627
7 
-32.0±1.9 
*p=0.34 
6.9±0.2 
*p=0.78 
0.1±0.01 
*p=0.50 
11
0.34±0.02 
*p=0.77 
11 
Cav2.12a -3.4±0.7 -4.1±0.2 54±1 21 -11.2±0.7 6.8±0.7 0.38±0.03 17 0.69±0.04 21 
Cav2.1(e47)2a 
-3.6±1.3 
**p=0.89 
-4.3±0.3 
**p=0.66 
54±1 
**p=0.83 
13
-11.0±1.5 
**p=0.91 
6.1±0.6 
**p=0.44 
0.36±0.10 
**p=0.75 
8 
0.70±0.08 
**p=0.89 
9 
Cav2.1(e47s)2a 
-3.2±1.4 
**p=0.87 
-4.3±0.4 
**p=0.67 
54±1 
**p=0.70 
10
-12.9±1.0 
**p=0.1781 
5.7±0.5 
**p=0.2040 
0.33±0.06 
**p=0.38 
11
0.64±0.05 
**p=0.43 
12 
Cav2.1C24 
-9.9±0.9 
p=0.50 
-3.4±0.2 
p=0.73 
53±1 
p=0.31 
16
-25.7±0.6 
p=0.0054 
7.0±0.3 
p=0.88 
0.13±0.02 
p=0.76 
18
0.45±0.03 
p=0.30 
17 
Cav2.1C24CT2 
-7.0±1.1 
***p=0.0473
-3.7±0.3 
***p=0.41 
53±1 
***p=0.88
19
-22.8±0.9 
***p=0.0120
7.8±0.3 
***p=0.0640
0.10±0.02 
***p=0.0918
18
0.38±0.03 
***p=0.065 
19 
Cav2.1C24CT2(e47) 
-7.1±1.2 
***p=0.0663
-4.4±0.6 
***p=0.0860
52±2 
***p=0.48
14
-24.0±1.5 
***p=0.29 
9.8±0.9 
***p=0.0033
0.12±0.03 
***p=0.63 
15
0.45±0.04 
***p=0.98 
14 
 
FIGURE CAPTIONS 
Figure 1. Summary of the events leading to the expression of Cav2.1 isoforms with different 
C-terminus sequences in the rat and mouse. (a) The use of an alternative acceptor site at the 
exon 46-47 boundary allows the insertion of the GGCAG sequence at the beginning of exon 47 
and the in-frame translation of exon 47, leading to Cav2.1 isoforms with full-length or deleted 
exon 47 in the rat (AAC24516, TCA50, CAJ09863, TCA56) and mouse (AAW56205, 
BAB85612, BAB85611). Conversely, omission of the GGCAG sequence causes a frameshift, 
leading to a stop codon at the beginning of exon 47 (AAC52940, AAC40806) (b) Alignment of 
the amino acid sequences of the extended C-terminus of rat and mouse Cav2.1. 
 
Figure 2. The short and the two long rat Cav2.1 variants show similar functional properties. (a) 
Schematic representation of the three rat Cav2.1, Cav2.1(e47) and Cav2.1(e47s) variants that 
differ at the C-terminus. The arrow indicates where the translation of human 1ACT begins 
(M1911). (b) Representative current traces recorded from X. laevis oocytes that express the 
indicated Cav subunit together with Cav4a and Cav21. Currents were elicited by 400ms-
long step depolarizations from a holding potential of -100 mV to potentials between -60 mV 
and +40 mV. Scale bars, 500 nA. (c) Current voltage curves (left), isochronal inactivation 
curves (middle), and R400 values (right) obtained for Cav2.1, Cav2.1(e47) and Cav2.1(e47s) 
in X. laevis oocytes that express the indicated Cav subunit together with Cav4a and 
Cav21. The parameters of both curves and the R400values are similar or marginally affected 
(see Table 1). n.s = non-significant. 
 
Figure 3. The rat Cav2.1, Cav2.1(e47) and Cav2.1(e47s) variants exhibit similar recovery from 
inactivation. (a) Representative current traces obtained in X. laevis oocytes that co-express the 
indicated Cav2.1 variants with Cav4a and Cav21. The experimental protocol is described 
above the traces. Depolarization to +10 mV for 5 s precedes a second 100ms-long 
depolarization to +10 mV after inter-pulse intervals between 100 ms and 8 s. Scale bar, 500 nA. 
(b) Percentage of current recovery plotted against the inter-pulse duration for the three variants. 
(c) The percentage of current recovery after 8 s of Cav2.1 is significantly smaller than that of 
Cav2.1(e47) (86 ± 1 %, n = 9 and 89 ± 1 %, n = 10, respectively; p = 0.0036) and is similar to 
that of Cav2.1(e47s) (85 ± 1 %, n = 6; p = 0.49). n.s = non-significant. 
 
Figure 4. Rat Cav2.1 variants produce C-terminal fragments that interact with Cav4a. (a) 
Western blot (WB) analysis of lysates from X. laevis oocytes that express Cav2.1, Cav2.1(e47) 
or Cav2.1(e47s) together with Cav4 and Cav21. The Cav subunits were detected with an 
anti-GFP antibody (top), while Cav4a was detected with a specific anti-Cav4 antibody 
(bottom). The expected molecular masses were 58, 278, 294 and 287 kDa for Cav4a, Cav2.1-
GFP, Cav2.1(e47)-GFP and Cav2.1(e47s)-GFP, respectively. The three variants produce C-
terminal fragments with an apparent molecular mass between 60 and 100 kDa, depending on 
the size of the Cav C-terminus. Doublets (asterisks) are due to GFP (see also Fig. 4b) and 
disappear when using the 6His tag (see Fig. 5d). NI, lysate obtained from non-injected oocytes. 
(b) Co-immunoprecipitation assays using protein lysates from HEK293 cells transfected with 
CT1-GFP or CT1(e47)-GFP alone or with Cav4a show the physical interaction of the Cav4 
with both C-terminal fragments. The expected molecular masses were 64 and 80 kDa for CT1-
GFP and CT1(e47)-GFP, respectively. 
 
Figure 5. Over-expression of C-terminal fragments does not affect Cav2.1 expression and 
functional properties. (a) Schematic representation of the deleted Cav2.1 (Cav2.1CT1), and 
the short (CT1) and the long (CT1(e47)) C-terminal fragments. (b) Representative current traces 
recorded from X. laevis oocytes injected with the indicated Cav subunit, Cav4a and 
Cav21, alone or with the short or the long C-terminal fragment tagged with 6His at the C-
terminus (1:1:1:1 molar ratio). Currents were elicited by 400ms-long step depolarizations from 
a holding potential of -100 mV to potentials between -60 mV and +40 mV. Scale bars, 500 nA. 
(c) Current voltage curves (left), isochronal inactivation curves (middle), and R400 values 
(right) obtained for Cav2.1 alone, or with the short or the long C-terminal fragment. The 
parameters of both curves and the R400 values are similar or marginally affected (see Table 1). 
(d) Western blot analysis of lysates from X. laevis oocytes injected with Cav2.1 alone (H2O), 
or with CT1-6His or CT1(e47)-6His and collected after recordings. The expected molecular 
masses were 38 and 54 kDa for CT1-6His and CT1(e47)-6His, respectively. NI, lysate obtained 
from non-injected oocytes. (e) Percentage of expressing oocytes in four independent 
experiments (right) and mean amplitude of the currents recorded from all the expressing oocytes 
in one of these four experiments (left). Oocytes were injected with Cav2.1, Cav4a and 
Cav21 alone, or with the short or the long C-terminal fragment (1:1:1:5 molar ratio), and 
recording performed two days later. The mean amplitude currents measured for Cav2.1 alone 
(1255 ± 176 nA, n = 19), with CT1 (1249 ± 122 nA, n = 11) or with CT1(e47) (1263 ± 177 nA, 
n = 18) were similar (p = 0.98 and p = 0.99, respectively). n.s = non-significant. 
 
Figure 6. Deletion of the Cav binding domain in Cav2.1 C-terminus does not affect Cav2.1 
functional properties. (a) Schematic representation of Cav2.1CT2 and the C-terminal 
fragments CT2 and CT2(e47). (b) Western blot analysis of lysates from X. laevis oocytes 
expressing Cav2.1 alone (H2O) or with CT2-6His or CT2(e47)-6His. The expected molecular 
masses were 22 kDa and 39 kDa for CT2-6His and CT2(e47)-6His, respectively. NI, lysate 
obtained from non-injected oocytes. (c) Representative current traces recorded from X. laevis 
oocytes injected with the indicated Cav subunit with Cav4a and Cav21, alone or with CT2 
or CT2(e47) (1:1:1:1 molar ratio). Currents were elicited by 400ms-long step depolarizations 
from a holding potential of -100 mV to potentials between -60 mV and +40 mV. Scale bars, 
500 nA. (d) Current voltage curves (left), isochronal inactivation curves (middle), and R400 
values (right) obtained for Cav2.1 alone, or with CT2-6His or CT2(e47)-6His. The parameters 
of both curves and the R400 values are similar or marginally affected (see Table 1). 
 






